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Purpose/Objective: The standard algorithm used for dose calculations 
of HDR brachytherapy plans conforms to the AAPM-TG43 formalism. 
Since this formalism is based on dose calculations in infinite water 
phantoms, its accuracy is limited in conditions such as near the body 
contours or in presence of inhomogeneities. On the other hand, Monte 
Carlo (MC) methods are able to calculate dose distributions very 
accurately. However, due to rather long computation times, MC 
methods aremainly used as benchmark for other dose calculation 
algorithms. In this work we present a validation and evaluation of the 
collapsed cone (CC) algorithm [1] with MC. 
Materials and Methods: In a first step, the Nucletron brachytherapy 
source microSelectron-HDR v2 has been implemented in the MC 
environment and validated against published AAPM-TG43 data from 
Taylor & Rogers [2]. For this purpose, the dose in a water sphere has 
been scored for a single source placed at the center. Furthermore, 
the CC algorithm has been validated, by comparing CC and MC 
calculated dose distributions for a single source placed at the center 
of a water cube. Primary and scatter dose components have been 
calculated according to the dose separation (PSS) formalism and 
compared individually. The second part of this work consists of the 
evaluation of the CC algorithm using 10 clinical treatment plans for 
breast cancer patients. For these plans, dose distributions have been 
calculated with CC and MC. 
Results: The local difference between the MC calculated dose 
distributions in the water sphere andthe AAPM TG43 data is less than 
1%. The comparison between the CC algorithm and MC in the cubic 
water phantom shows differences up to 2% of the reference dose 
(dosein 1 cm from the source on its equatorial plane) for distances > 2 
cm from the source. These differences can be assigned to the first and 
residual scatter dose component, while the primary dose component 
is accurately modeled. Calculated CC doses on clinical breast cancer 
cases in general agree well with dose distribution simulated with MC. 
In the high-dose region (> 100% of the prescribed dose), CC 
underestimates the MC dose by as much as 2%. It was found that this 
deviation is correlated with the geometrical size of the CT data set. If 
the CT data set extends the PTV by an appropriate amount, the 
underestimation falls below 1%. 
Conclusions: The CC algorithm is an accurate dose calculation 
algorithm and improves the dose calculation accuracy in 
brachytherapy, particularly for situations where the AAPM-TG43 
formalism has some limitations. This work was supported by 
Nucletron.  
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Purpose/Objective: The brachytherapy (BT) version of the collapsed 
cone (CC) algorithm is under implementation in the Oncentra 
treatment planning system (Nucletron – an Elekta Company, 
Veenendal, the Netherlands). CC is a point kernel superposition 
algorithm that treats the dose from multiply scattered photons with 
the approximation of the phantom size used to generate the kernel. 
This study assesses the performance of the CC with various clinical 
cases with kernel sizes selected to take into account the finite 
phantom size and the presence of material interfaces. 
Materials and Methods: In this work we use the BT CC algorithm 
version 0.4.0 to calculate the dose in a number of clinical prostate 
and breast cases. Point kernels for residual scatter were derived in 
water phantoms of different dimensions with radii ranging from 10 to 
50 cm. Results are compared with Geant4 Monte Carlo (MC) 
simulations using the same geometries and material descriptions 
based on the complete DICOM-RT data. Criteria based on DVHs and 
the local dose agreement at interfaces determine the optimal kernel 
size to use in each case. All calculations were generated using a 
relatively high number of cones, 720 and 500 for the first and residual 
scatters respectively. 
Results:  
 
Prostate HDR brachytherapy cases were calculated in a voxelized 
geometry containing 963 voxels (each 2x2x2mm3). A smaller kernel 
size of 10 cm substantially improves the general agreement with MC 
over the entire phantom volume in comparison to the default value of 
50 cm. As shown in the figure for a typical prostate case, the CC 
overestimation towards the phantom edges decreases from 12% to less 
than 4% using a 10 cm kernel in prostate cases. Dose profiles in 
peripheral organs at risks like the rectum and bladder are accurately 
described with the latter choice. The measured D90 parameters are 
all precise at the 1% level irrespective of the kernel size. Slightly 
better values are obtained close to the source positions with larger 
kernel sizes, suggesting that a better agreement could be obtained 
with a choice of kernel sizes dependent on the distance to the closest 
boundary. A situation with tissue-air interfaces like in a breast case 
would also benefit from smaller kernels and a treatment with a 
Mammosite applicator has been studied. A 10 cm kernel gives better 
dose predictions and improves the skin dose to a precision below 2% 
relative to MC; this represents a two-fold reduction compared to the 
larger kernels. 
Conclusions: This study suggests that tissue-air interfaces in breast 
cases as well as limited-size geometry in prostate cases are described 
accurately using smaller kernel sizes. An adaptive kernel sizes 
selection would further improve the performance of the algorithm to 
all regions of interests. 
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Purpose/Objective: The TG-186 report has updated guidelines for 
reporting dose in brachytherapy. The current TG-43 protocol ignores 
the effects of tissue heterogeneity and patient geometry on dose 
distributions from low energy sources(<50keV). One alternative dose 
calculation method is Monte Carlo (MC) dosimetry, which can 
accurately calculate dose distributions in realistic patient geometries 
such as those derived from CT imaging. A miniature low energy 
electronic x-ray source, Xoft Axxent, is currently used for accelerated 
partial breast irradiation (APBI). Recent literature indicates the 
importance of properly segmenting adipose and mammary tissue for 
breast dose calculation with low energy photons. The purpose of this 
study is to highlight the importance of proper tissue segmentation, 
applicator modeling and radiation transport in APBI by reporting the 
dose discrepancies stemming from the usage of TG-43 dosimetry. 
Materials and Methods: The GEANT4 Monte Carlo code was used to 
simulate dose distributions in 8 APBI patient geometry. Patient CT 
images were voxelized and segmented into various tissues based on a 
breast modeling scheme. The balloon applicator was modeled using 
manufacturer's data. The source was a phase space file derived from 
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the validated source model. The MC simulations were done using the 
original treatment parameters; source strength, dwell positions and 
times. The MC dose metrics for PTV and skin D90 and D0.1cc were 
compared to the TG-43 treatment plan. 
Results: A validation simulation using a water-based geometry agreed 
to within 1% of the treatment plan's D90. The patient dose was scored 
in terms of dose to water in medium (Dw,m) and compared against the 
TG-43 plan (Dw,w) (figure). All dose metrics demonstrate a decrease in 
Dw,m compared to Dw,w on the order of 10-30%. The TG-43 D90 is 
reduced by 20% in Dw,m. The D0.1cc for the skin showed a 30% reduction 
when recalculated in MC. The reduction is the result of a complex 
combination of factors such as tissue heterogeneity, loss of 
backscatter at the skin/lung interface and the applicator design, in 
particular the wall of the balloon applicator which reduces the dose 
fluence by approximately 7% due to the presence of barium sulfate (a 
high-Z compound).  
 
  
Figure: Top Right: Isodose comparison of MC-based(solid lines) versus 
TG-43-based dosimetry (dashed lines) Bottom: Ratio of Dw,w to Dw,m. 
Black lines denotes PTV. Dw,m to air/lung is reported as zero. Top left: 
HU-based tissue segmentation of the breast. 
 
Conclusions: Results indicate that effects of under-dosing on the dose 
distribution for Dw,m compared to Dw,w. This study demonstrates the 
need for more comprehensive dosimetry model to the current TG-43 
dose formulation.  
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Purpose/Objective: Model based dose calculation algorithms 
(MBDCAs), recently introduced in treatment planning systems for 
brachytherapy (BT), calculate absorbed doses to the medium (i.e. to 
the tissues). The aim of this work was to shed light on the yet 
unresolved issue of which method for converting absorbed dose to 
medium Dm,m into absorbed dose to water Dw,m is most suitable for BT. 
'Small cavity theory' implies conversion by stopping power ratios and is 
applicable when ranges of secondary electrons are long compared to 
cavity dimensions while 'large cavity theory' implies conversion by 
ratios of mass energy absorption coefficients and is applicable when 
ranges are short in relation to cavity dimensions. The relationship 
between cavity size and applicable cavity theory at the photon 
energies of interest to BT, i.e., in the energy range 20-1000 keV, was 
investigated. An argument in favor of reporting Dw,m has been that 
there exists a radiotherapy target being of cellular dimensions that is 
more water-like in all tissues than the average bulk medium obtained 
from CT images and used in MBDCA calculations. 
Materials and Methods: Burlin cavity theory was applied to estimate 
photon energies at which cavity sizes in the range 1 nm -10 mm can 
be considered small or large. Photon- and electron energy spectra 
were calculated at 1 cm distance from the central axis in phantoms of 
bone, muscle and adipose tissue for centrally placed 20, 50, 300 keV, 
125I, 169Yb and 192Ir photon point sources; ratios of mass collision-
stopping powers and mass energy absorption coefficients were 
calculated as applicable to convert Dmed into Dw,med for small and large 
cavities.  
Results: The figure shows the parameter d in the Burlin theory as 
function of photon energy and cavity size; a cavity is small when d is 
close to unity and large when d is close to zero.  
1-10 nm sized cavities are small at all investigated photon energies; 
100 μm cavities are large only at photon energies < 20 keV and 
cavities of mm dimensions are required for large cavity theory to be 
suitable at 192Ir photon energies around 300 keV.  
 Conclusions: The question whether to report Dm,m or Dw,m arises when 
using MBDCAs for BT similar to in external beam therapy. However in 
BT the additional problem of deciding appropriate cavity dimensions 
arises due to the short ranges of secondary electrons. Free radicals 
from DNA bound water of nm dimensions contribute to complex DNA 
damage and cell killing and may be the most important water 
compartment in cells which would imply use of ratios of mass-collision 
stopping-powers for converting Dm into Dw,m in BT as used in external 
beam therapy. Stopping power ratios vary little with energy and lead 
to numerical values for Dw,m/Dm,m similar to those reported for other 
radiotherapy modalities. Mass energy absorption coefficient ratios 
imply large differences in Dm /Dw,m over the BT energy range and to 
those obtained in external beam therapy. 
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Purpose/Objective: To analyse late urogenital (UG), gastrointestinal 
(GI) and vaginal (VG) morbidity in patients treated for cervical cancer 
by IGABT in a multicentre setting. 
Materials and Methods: RetroEMBRACE is a retrospective collection of 
data from patients treated for cervical cancer by IGABT using the 
GEC-ESTRO guidelines. At present, 796 patients have been registered 
from 12 institutions. Detailed data on morbidity grade 1-5 (CTCAE, 
V3.0) has been entered in 533 patients from 5 institutions. In these 
patients, FIGO-stage was IB1-IIA/IIB/IIIA-IVAB in 28%/48%/24%. Eighty-
four percent were squamous cell carcinomas. In all patients IGABT 
was preceded by 3D conformal radiotherapy or Intensity Modulated 
Radiotherapy with mean dose of 46 ±3 Gy in 26 ±2 fractions and 
weekly concomitant cisplatinum in 76%. A nodal boost of 57 ±3 Gy was 
given to 16% and a parametrial boost of 55 ±2 Gy was given to 4%. 
